Companies › SPRB
SPRUCE BIOSCIENCES INC COM NEW (SPRB)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001683553 · EDGAR filings · Updated 2026-07-27
SPRUCE BIOSCIENCES INC COM NEW (SPRB) has reported institutional ownership of 53.9%, with 32 institutional managers holding positions valued at $48.3M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (2)
- 2026-07-27 — SCHEDULE 13G filed
- 2026-07-27 — Current report (8-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-09 — Insider transaction reported (Form 4)
- 2026-05-26 — Insider transaction reported (Form 4)
- 2026-05-26 — Insider transaction reported (Form 4)
- 2026-05-26 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, SPRUCE BIOSCIENCES INC COM NEW has 32 institutional holders and institutional ownership of 53.9%.
Insider activity
Insiders reported 28 transactions (2 buys, 4 sells) across 4 reporting insiders, with a net reported value of −$672.
Data flags from SEC filings
Related companies
Inovio Pharmaceuticals Inc (INO) · BIODESIX INC (BDSX) · MESOBLAST LTD (MESO) · Spero Therapeutics Inc (SPRO) · CARLSMED INC (CARL) · Assertio Holdings Inc (ASRT)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.